Chrobok, M.; Dahlberg, C.I.M.; Sayitoglu, E.C.; Beljanski, V.; Nahi, H.; Gilljam, M.; Stellan, B.; Sutlu, T.; Duru, A.D.; Alici, E.
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells. Cancers 2019, 11, 69.
https://doi.org/10.3390/cancers11010069
AMA Style
Chrobok M, Dahlberg CIM, Sayitoglu EC, Beljanski V, Nahi H, Gilljam M, Stellan B, Sutlu T, Duru AD, Alici E.
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells. Cancers. 2019; 11(1):69.
https://doi.org/10.3390/cancers11010069
Chicago/Turabian Style
Chrobok, Michael, Carin I. M. Dahlberg, Ece Canan Sayitoglu, Vladimir Beljanski, Hareth Nahi, Mari Gilljam, Birgitta Stellan, Tolga Sutlu, Adil Doganay Duru, and Evren Alici.
2019. "Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells" Cancers 11, no. 1: 69.
https://doi.org/10.3390/cancers11010069
APA Style
Chrobok, M., Dahlberg, C. I. M., Sayitoglu, E. C., Beljanski, V., Nahi, H., Gilljam, M., Stellan, B., Sutlu, T., Duru, A. D., & Alici, E.
(2019). Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells. Cancers, 11(1), 69.
https://doi.org/10.3390/cancers11010069